홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

5,6-Dichloronicotinic acid → Tert-butyl {4-[5-(5,6-dichloropyridin-3-yl)-1,2,4-oxadiazol-3-yl]-2-fluorophenoxy}acetate

HRID 219931
인쇄

반응식

HRID 219931 반응식
[NH2:1][C:2](=[N:19][OH:20])[C:3]1[CH:17]=[CH:16][C:6]([O:7][CH2:8][C:9]([O:11][C:12]([CH3:15])([CH3:14])[CH3:13])=[O:10])=[C:5]([F:18])[CH:4]=1.[Cl:21][C:22]1[C:23]([Cl:31])=[N:24][CH:25]=[C:26]([CH:30]=1)[C:27](O)=O>>[Cl:21][C:22]1[CH:30]=[C:26]([C:27]2[O:20][N:19]=[C:2]([C:3]3[CH:17]=[CH:16][C:6]([O:7][CH2:8][C:9]([O:11][C:12]([CH3:15])([CH3:13])[CH3:14])=[O:10])=[C:5]([F:18])[CH:4]=3)[N:1]=2)[CH:25]=[N:24][C:23]=1[Cl:31]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 2479875,6-Dichloronicotinic acidHCID 72307490Tert-butyl {4-[amino(hydroxyimino)methyl]-2-fluorophenoxy}acetate

생성물 1

HCID 86645655Tert-butyl {4-[5-(5,6-dichloropyridin-3-yl)-1,2,4-oxadiazol-3-yl]-2-fluorophenoxy}acetate

실험 절차

The title compound was prepared following procedure described for example 4, step 1, but starting from Intermediate 49 (995.01 mg; 3.50 mmol) and 5,6-dichloronicotinic acid (806.4 mg; 4.2 mmol). The reaction mixture was evaporated. The crude product was dissolved in EtOAc and washed with NH4Cl sat, NaHCO3 sat, brine and dried over MgSO4. After evaporation of the solvents, the resulting solid was suspended in MeCN and filtrated, affording the title compound as an off-white solid. LC/MS (Method B): 420.3 (M−H)−. HPLC (Method A) Rt 5.72 min (Purity: 99.4%).

후처리

  1. customThe title compound was prepared following procedure
  2. customThe reaction mixture was evaporated
  3. dissolutionThe crude product was dissolved in EtOAc
  4. washwashed with NH4Cl
  5. dry with materialbrine and dried over MgSO4
  6. customAfter evaporation of the solvents
  7. filtrationfiltrated

출처 및 근거

ORD 기록
ord-64d62b24c1d7405aa1b1f815f1046f9c
출처 데이터셋
uspto-grants-2012_06
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08202865B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트